Logo image
Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human Microcirculation
Journal article   Open access   Peer reviewed

Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human Microcirculation

Andreas M Beyer, Julie K Freed, Matthew J Durand, Michael Riedel, Karima Ait-Aissa, Paula Green, Joseph C Hockenberry, R Garret Morgan, Anthony J Donato, Refael Peleg, …
Circulation research, Vol.118(5), pp.856-866
03/04/2016
DOI: 10.1161/CIRCRESAHA.115.307918
PMCID: PMC4772813
PMID: 26699654
url
https://doi.org/10.1161/circresaha.115.307918View
Published (Version of record) Open Access

Abstract

Telomerase is a nuclear regulator of telomere elongation with recent reports suggesting a role in regulation of mitochondrial reactive oxygen species. Flow-mediated dilation in patients with cardiovascular disease is dependent on the formation of reactive oxygen species. We examined the hypothesis that telomerase activity modulates microvascular flow-mediated dilation, and loss of telomerase activity contributes to the change of mediator from nitric oxide to mitochondrial hydrogen peroxide in patients with coronary artery disease (CAD). Human coronary and adipose arterioles were isolated for videomicroscopy. Flow-mediated dilation was measured in vessels pretreated with the telomerase inhibitor BIBR-1532 or vehicle. Statistical differences between groups were determined using a 2-way analysis of variance repeated measure (n≥4; P<0.05). L-NAME (N(ω)-nitro-L-arginine methyl ester; nitric oxide synthase inhibitor) abolished flow-mediated dilation in arterioles from subjects without CAD, whereas polyethylene glycol-catalase (PEG-catalase; hydrogen peroxide scavenger) had no effect. After exposure to BIBR-1532, arterioles from non-CAD subjects maintained the magnitude of dilation but changed the mediator from nitric oxide to mitochondrial hydrogen peroxide (% max diameter at 100 cm H2O: vehicle 74.6±4.1, L-NAME 37.0±2.0*, PEG-catalase 82.1±2.8; BIBR-1532 69.9±4.0, L-NAME 84.7±2.2, PEG-catalase 36.5±6.9*). Conversely, treatment of microvessels from CAD patients with the telomerase activator AGS 499 converted the PEG-catalase-inhibitable dilation to one mediated by nitric oxide (% max diameter at 100 cm H2O: adipose, AGS 499 78.5±3.9; L-NAME 10.9±17.5*; PEG-catalase 79.2±4.9). Endothelial-independent dilation was not altered with either treatment. We have identified a novel role for telomerase in re-establishing a physiological mechanism of vasodilation in arterioles from subjects with CAD. These findings suggest a new target for reducing the oxidative milieu in the microvasculature of patients with CAD.
Adipose Tissue - blood supply Adipose Tissue - enzymology Aged Arterioles - enzymology Blood Flow Velocity - physiology Cells, Cultured Coronary Artery Disease - enzymology Coronary Artery Disease - pathology Coronary Vessels - enzymology Endothelium, Vascular - enzymology Female Human Umbilical Vein Endothelial Cells - enzymology Humans Male Microcirculation - physiology Middle Aged Telomerase - physiology Vasodilation - physiology

Details

Metrics

Logo image